Product
LX109
1 clinical trial
1 indication
Indication
nAMDClinical trial
An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD)Status: Not yet recruiting, Estimated PCD: 2025-09-30